Awosan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Awosan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Abe
Department of Pharmacology and Therapeutics, Faculty of Basic Medical Sciences, College of Health Sciences, Ladoke Akintola University of Technology, Ogbomoso,Nigeria
1 shared publication - Adeyeba Oluwaseyi Adegboyega
Department of Microbiology and Parasitology, Ladoke Akintola University of Technology Ogbomoso, Osogbo,Nigeria
1 shared publication Mokaila K. Olapade
Department of Pharmacology and Therapeutics, Faculty of Basic Medical Sciences, College of Health Sciences, Ladoke Akintola University of Technology, Ogbomoso,Nigeria
1 shared publication- Olatoyan-Layonu
Department of Pharmacology and Therapeutics, Faculty of Basic Medical Sciences, College of Health Sciences, Ladoke Akintola University of Technology, Ogbomoso,Nigeria
1 shared publication - Olayemi Kamoru Wakeel
Department of Pharmacology and Therapeutic, Faculty of Basic Clinical Sciences, College of Health Sciences, Ladoke Akintola University of Technology Ogbomoso, Nigeria
1 shared publication - Olugbenga Adekunle Olowe
Department of Medical Microbiology and Parasitology, Ladoke Akintola University of Technology, 210214 Ogbomoso, Oyo State, Nigeria
1 shared publication
Latest Publications
- 1 June 2021
- Published by Bentham Science Publishers Ltd. in Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
- Vol. 20 (2) , 206-218
Anti-Nociceptive and Anti-Inflammatory Effects of Stem Bark Extract of Ficus Capensis Thunb (Moraceae) by Bioactivity Fractionation
Objective: This study investigated the anti-nociceptive and anti-inflammatory activities of the aqueous extract of Ficus capensis (AEFC) by bio-guided fractionation. Methods: The anti-nociceptive and anti-inflammatory effects of AEFC (250, 500, 1000 mg/kg, i.p) were assessed using acetic acid-induced writhing, hot plate, tail-flick, formalin tests, and carrageenan-induced paw oedema respectively. The AEFC was fractionated base on polarity different into butanol, ethyl acetate, and n-hexane fractions. The fractions (500 mg/kg) obtained were subjected to the same experimental procedures mentioned above. The EAF, which exerted the most productive activities, was further subjected to fractionation procedures that yielded six fractions (labeled CF1-CF6). These fractions (200 mg/kg) were tested for potential anti-nociceptive and anti-inflammatory activities. Notable antagonists (Naloxone and atropine) of nociceptive pathway were used to evaluate the mechanism of the anti-nociceptive action of F. capensis. Results and Discussion: The AEFC, BF, EAF, and CF4 caused a significant (p<0.05) reduction in the number of abdominal writhes, an increase in reaction time against the hot plate, tail-flick tests, and a significant (p<0.05) inhibition in both phases of formalin test. The AEFC, BF, EAF, CF4, and CF6 caused a significant (p<0.05) inhibition of paw edema development due to carrageenan. Atropine significantly reversed the antinociceptive effect of CF4 in both phases of the formalin test. The results obtained revealed that CF4 produced central and peripheral antinociceptive effects, while CF6 is peripherally mediated. Conclusion: The results support the traditional uses of F. capensis in the treatment of various diseases associated with pain and inflammation. The column fraction CF4 exhibited muscarinic receptor-mediated anti-nociceptive activity.
- 1 June 2021
- Published by Bentham Science Publishers Ltd. in Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
- Vol. 20 (2) , 206-218
Anti-Nociceptive and Anti-Inflammatory Effects of Stem Bark Extract of Ficus Capensis Thunb (Moraceae) by Bioactivity Fractionation
Objective: This study investigated the anti-nociceptive and anti-inflammatory activities of the aqueous extract of Ficus capensis (AEFC) by bio-guided fractionation. Methods: The anti-nociceptive and anti-inflammatory effects of AEFC (250, 500, 1000 mg/kg, i.p) were assessed using acetic acid-induced writhing, hot plate, tail-flick, formalin tests, and carrageenan-induced paw oedema respectively. The AEFC was fractionated base on polarity different into butanol, ethyl acetate, and n-hexane fractions. The fractions (500 mg/kg) obtained were subjected to the same experimental procedures mentioned above. The EAF, which exerted the most productive activities, was further subjected to fractionation procedures that yielded six fractions (labeled CF1-CF6). These fractions (200 mg/kg) were tested for potential anti-nociceptive and anti-inflammatory activities. Notable antagonists (Naloxone and atropine) of nociceptive pathway were used to evaluate the mechanism of the anti-nociceptive action of F. capensis. Results and Discussion: The AEFC, BF, EAF, and CF4 caused a significant (p<0.05) reduction in the number of abdominal writhes, an increase in reaction time against the hot plate, tail-flick tests, and a significant (p<0.05) inhibition in both phases of formalin test. The AEFC, BF, EAF, CF4, and CF6 caused a significant (p<0.05) inhibition of paw edema development due to carrageenan. Atropine significantly reversed the antinociceptive effect of CF4 in both phases of the formalin test. The results obtained revealed that CF4 produced central and peripheral antinociceptive effects, while CF6 is peripherally mediated. Conclusion: The results support the traditional uses of F. capensis in the treatment of various diseases associated with pain and inflammation. The column fraction CF4 exhibited muscarinic receptor-mediated anti-nociceptive activity.